Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Peter-like Biotechnology is a specialized life sciences company based in Chengdu, China, focusing on the extraction, purification, and commercialization of high-purity natural products and reference standards. The company provides a wide range of phytochemicals, including saponins, alkaloids, and flavonoids, which are essential for pharmaceutical research, quality control, and drug discovery. Peter-like Biotechnology serves global pharmaceutical companies, research institutions, and testing laboratories by offering custom synthesis and contract research services. Their expertise lies in the isolation of complex compounds from traditional Chinese medicine and other botanical sources. They maintain a large inventory of reference standards to support the standardization of herbal medicines and provide analytical services to ensure compound identity and purity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Peter-like Biotechnology.